Genital Necrotizing Fasciitis: Fournier's Gangrene
DOI:
https://doi.org/10.17140/DRMTOJ-1-109Abstract
Necrotizing fasciitis is characterized by a rapidly progressive infectious disease affecting skin
and soft tissue, usually accompanied by severe systemic toxicity. In fact, it is considered the
most serious expression of soft tissue infection, by its rapid destruction and tissue necrosis,
reaching more than 30% of patients checkered shock and organ failure. In recent years,
its incidence is reported at 1: 100,000. This entity in the case of perineal and genital tract
involvement, it is called Fournier’s gangrene. In the specialty of Obstetrics and Gynecology is
a rare infectious complication
References
JI Rodríguez Hermosa, A Codina Cazador, MJ García Oria, et al. Fournier’s gangrene. Cir Esp. 2001; 69(2): 128-135. doi: 10.1016/S0009-739X(01)71710-1
Chennamsetty A, Khourdaji I, Burks F, Killinger KA. Contem-porary diagnosis and management of Fournier’s gangrene.Ther Adv Urol. 2015; 7(4): 203-215. doi: 10.1177/1756287215584740
Pedro PC, Silvia PE, María Ester PR, Santos CS, Jesús Alberto GV. Actualización en fascitis necrotizante. Semin Fund Esp Reu-matol. 2012; 13(2): 41-48. doi: 10.1016/j.semreu.2011.12.005
Gallup DG, Freedman MA, Meguiar RV, Freedman SN, Nolan TE. Necrotizing fasciitis in gynecologic and obstetric patienta: a surgical emergency. Am J Obstet Gynecol. 2002; 187(2): 305- 310. doi: 10.1067/mob.2002.126000
Medina Polo J, Tejido Sánchez A, de la Rosa Kehrmann F, Felip Santamaría N, Blanco Álvarez M, Leiva Galvis O. Fournier gangrene: Evaluation of prognostic factors in 90 patients. Actas Urol Esp. 2008; 32(10): 1024-1030. doi: 10.1016/S0210- 4806(08)73982-2
Wong C, Khin L, Heng K, Tan K, Low C. The LRINEC (Laboratory Risk Indicator for Necrotizing fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004; 32(7): 1535-1541. doi: 10.1097/01.CCM.0000129486.35458.7D
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Dermatology (DER) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.